Is there a predisposition to uveitis in Turner syndrome?

IF 1.2 4区 医学 Q4 GENETICS & HEREDITY
Ophthalmic Genetics Pub Date : 2025-06-01 Epub Date: 2025-03-04 DOI:10.1080/13816810.2025.2473970
Kirk A J Stephenson, Shanil R Dhanji, Kaivon Pakzad-Vaezi
{"title":"Is there a predisposition to uveitis in Turner syndrome?","authors":"Kirk A J Stephenson, Shanil R Dhanji, Kaivon Pakzad-Vaezi","doi":"10.1080/13816810.2025.2473970","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Autoimmunity is prevalent in Turner syndrome (TS) though uveitis is rarely reported. A definite link between TS and uveitis is not yet established.</p><p><strong>Methods: </strong>We report two cases of uveitis with a history of TS and review the literature regarding TS, uveitis and autoimmunity.</p><p><strong>Results: </strong>TS-associated uveitis is acute (100%), non-hypertensive (100%) anterior uveitis (87.5%) that usually responds to topical therapy without unexpected long-term visual sequelae. Systemic treatment is uncommonly required as relapses are infrequent.</p><p><strong>Conclusion: </strong>Reported cases of uveitis in TS were acute/symptomatic, normotensive and both unilateral and bilateral cases have been described. Systemic causes including infectious (e.g. syphilis, tuberculosis), noninfectious (e.g. sarcoidosis, HLA-B27) and specific syndromes (e.g. tubulointerstitial nephritis with uveitis, juvenile idiopathic arthritis) should be sought. Systemic immunosuppression was not needed in most cases as a good response to topical therapy was typical. There are baseline risks in TS (e.g. further growth limitation in children, baseline increased risk of solid tumors, diabetes mellitus), which should be considered before commencing systemic corticosteroids or immunosuppressants.</p>","PeriodicalId":19594,"journal":{"name":"Ophthalmic Genetics","volume":" ","pages":"297-300"},"PeriodicalIF":1.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13816810.2025.2473970","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/4 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Autoimmunity is prevalent in Turner syndrome (TS) though uveitis is rarely reported. A definite link between TS and uveitis is not yet established.

Methods: We report two cases of uveitis with a history of TS and review the literature regarding TS, uveitis and autoimmunity.

Results: TS-associated uveitis is acute (100%), non-hypertensive (100%) anterior uveitis (87.5%) that usually responds to topical therapy without unexpected long-term visual sequelae. Systemic treatment is uncommonly required as relapses are infrequent.

Conclusion: Reported cases of uveitis in TS were acute/symptomatic, normotensive and both unilateral and bilateral cases have been described. Systemic causes including infectious (e.g. syphilis, tuberculosis), noninfectious (e.g. sarcoidosis, HLA-B27) and specific syndromes (e.g. tubulointerstitial nephritis with uveitis, juvenile idiopathic arthritis) should be sought. Systemic immunosuppression was not needed in most cases as a good response to topical therapy was typical. There are baseline risks in TS (e.g. further growth limitation in children, baseline increased risk of solid tumors, diabetes mellitus), which should be considered before commencing systemic corticosteroids or immunosuppressants.

特纳综合征患者是否易患葡萄膜炎?
自体免疫在特纳综合征(TS)中普遍存在,但葡萄膜炎很少报道。TS和葡萄膜炎之间的确切联系尚未确定。方法:我们报告了2例伴有TS病史的葡萄膜炎,并回顾了有关TS、葡萄膜炎和自身免疫的文献。结果:ts相关性葡萄膜炎为急性(100%),非高血压性(100%)前葡萄膜炎(87.5%),通常对局部治疗有反应,无意外的长期视力后遗症。由于复发很少,一般不需要全身治疗。结论:报告的TS患者葡萄膜炎均为急性/症状性,血压正常,单侧和双侧均有报道。系统性病因包括感染性(如梅毒、肺结核)、非感染性(如结节病、HLA-B27)和特异性综合征(如葡萄膜炎伴小管间质性肾炎、幼年特发性关节炎)。大多数情况下不需要全身免疫抑制,因为局部治疗的反应很好。TS存在基线风险(例如,儿童的进一步生长限制、实体瘤、糖尿病基线风险增加),在开始使用全身皮质类固醇或免疫抑制剂之前应考虑这些风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ophthalmic Genetics
Ophthalmic Genetics 医学-眼科学
CiteScore
2.40
自引率
8.30%
发文量
126
审稿时长
>12 weeks
期刊介绍: Ophthalmic Genetics accepts original papers, review articles and short communications on the clinical and molecular genetic aspects of ocular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信